Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO

NCT01157299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-07-07

No results posted yet for this study

Summary

The purpose of this study is

* To assess the value of dynamics (SVV, PPV) and static indices (GEDVI, ITBVI, CVP) of preload and its combination with contractility (CI,SV, ventricular power, dP/dtmax, CFI, GEF) and lung water indices (ELWI), as predictors of fluid responsiveness in both spontaneously breathing and mechanically ventilated pediatric patients.
* To assess the value of stroke volume and pulse pressure changes from femoral pulse contour analysis (PiCCO2) during passive leg raising as predictor of fluid responsiveness in pediatric patients.
* To establish normal and cutoff values of transpulmonary thermodilution (PiCCO2) hemodynamic variables in hemodynamically stables and hemodynamically "normal" patients.

Conditions

  • Shock
  • Sepsis
  • Systemic Inflammatory Response Syndrome
  • Low Cardiac Output
  • Dilated Cardiomyopathy

Sponsors & Collaborators

  • Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Pedro de la Oliva, MD PhD. · Hospital Universitario La Paz

  • Ignacio Sánchez-Díaz, MD PhD · Hospital Universitario 12 de Octubre de Madrid

  • Elena Alvarez-Rojas, MD · Hospital Universitario Ramón y Cajal de Madrid

  • Susana Jaraba-Caballero, MD · Hospital Universitario Reina Sofia de Córdoba

  • Patricia Roselló-Millet, MD · Hospital Clínico Universitario de Valencia

  • José Manuel González-Gómez, MD · Hospital Universitario Carlos Haya de Málaga

  • Ana Serrano-Gonzalez, MD PhD · Hospital Infantil Universitario del Niño Jesús

  • Eduardo Consuegra-Llapur, MD · Hospital Universitario Materno-Infantil de las Palmas de Gran Canaria

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-08-31
Completion
2010-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01157299 on ClinicalTrials.gov